SG10201807682PA - Methods of Treating or Preventing Respiratory Conditions - Google Patents
Methods of Treating or Preventing Respiratory ConditionsInfo
- Publication number
- SG10201807682PA SG10201807682PA SG10201807682PA SG10201807682PA SG10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA SG 10201807682P A SG10201807682P A SG 10201807682PA
- Authority
- SG
- Singapore
- Prior art keywords
- treating
- respiratory
- methods
- subject
- preventing respiratory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736352P | 2012-12-12 | 2012-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201807682PA true SG10201807682PA (en) | 2018-10-30 |
Family
ID=50933587
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504352TA SG11201504352TA (en) | 2012-12-12 | 2013-12-12 | Methods of treating or preventing respiratory conditions |
| SG10201807682PA SG10201807682PA (en) | 2012-12-12 | 2013-12-12 | Methods of Treating or Preventing Respiratory Conditions |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504352TA SG11201504352TA (en) | 2012-12-12 | 2013-12-12 | Methods of treating or preventing respiratory conditions |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10028979B2 (zh) |
| EP (1) | EP2931373B1 (zh) |
| JP (5) | JP6313327B2 (zh) |
| KR (1) | KR101748712B1 (zh) |
| CN (2) | CN105377274A (zh) |
| AU (4) | AU2013360026B2 (zh) |
| CA (1) | CA2893951C (zh) |
| ES (1) | ES2759281T3 (zh) |
| HK (1) | HK1210077A1 (zh) |
| IL (1) | IL239309A0 (zh) |
| SG (2) | SG11201504352TA (zh) |
| WO (1) | WO2014089625A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105377274A (zh) | 2012-12-12 | 2016-03-02 | 麦瑟布莱斯特公司 | 治疗或预防呼吸病症的方法 |
| WO2016049156A1 (en) * | 2014-09-23 | 2016-03-31 | Case Western Reserve University | Compositions and methods for treating lung remodeling diseases |
| CA3074470C (en) * | 2017-09-15 | 2024-01-16 | Cynata Therapeutics Limited | Method for treating allergic airways disease (aad)/ asthma |
| CN110680833A (zh) * | 2018-06-20 | 2020-01-14 | 中国科学院遗传与发育生物学研究所 | 一种结合肺灌洗治疗尘肺病的套药 |
| TW202146033A (zh) * | 2020-01-30 | 2021-12-16 | 日商Ｊｃｒ製藥股份有限公司 | 包含源自牙髓的細胞之醫藥組成物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
| KR100489248B1 (ko) * | 2002-02-19 | 2005-05-11 | 메디포스트(주) | 제대혈 유래 간엽줄기세포ㆍ전구세포의 분리배양방법 및간엽조직으로의 분화유도방법 |
| US20080095749A1 (en) * | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| KR101441026B1 (ko) | 2004-09-24 | 2014-10-01 | 메소블라스트, 아이엔씨. | 증폭된 다능성 간엽 전구세포 자손 및 이의 용도 |
| AU2006235211B2 (en) | 2005-04-12 | 2010-10-14 | Mesoblast, Inc. | Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
| WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
| US20090053182A1 (en) * | 2007-05-25 | 2009-02-26 | Medistem Laboratories, Inc. | Endometrial stem cells and methods of making and using same |
| CN103169731A (zh) * | 2007-08-06 | 2013-06-26 | 成血管细胞系统公司 | 用于体内生成、修复和/或维护结缔组织的方法 |
| WO2009050282A1 (en) * | 2007-10-17 | 2009-04-23 | Txcell | Tr1 cells, mesenchymal stem cells and uses thereof |
| SG193888A1 (en) * | 2008-09-03 | 2013-10-30 | Mesoblast Inc | Expansion of haemopoietic precursors |
| EP2593114B1 (en) * | 2010-07-02 | 2018-01-10 | Mesoblast, Inc. | Cells expressing stro-1 bright for treating graft versus host disease |
| WO2012125471A1 (en) * | 2011-03-11 | 2012-09-20 | Children's Medical Center Corporation | Methods and compositions relating to mesenchymal stem cell exosomes |
| US10206951B2 (en) | 2011-06-03 | 2019-02-19 | Mesoblast, Inc. | Methods of treating multiple sclerosis using STRO-1+ and TNAP+ multipotential cells |
| CN105377274A (zh) | 2012-12-12 | 2016-03-02 | 麦瑟布莱斯特公司 | 治疗或预防呼吸病症的方法 |
-
2013
- 2013-12-12 CN CN201380072492.9A patent/CN105377274A/zh active Pending
- 2013-12-12 SG SG11201504352TA patent/SG11201504352TA/en unknown
- 2013-12-12 CN CN202310100395.1A patent/CN115919901A/zh active Pending
- 2013-12-12 WO PCT/AU2013/001454 patent/WO2014089625A1/en active Application Filing
- 2013-12-12 US US14/650,171 patent/US10028979B2/en active Active
- 2013-12-12 AU AU2013360026A patent/AU2013360026B2/en active Active
- 2013-12-12 CA CA2893951A patent/CA2893951C/en active Active
- 2013-12-12 JP JP2015546771A patent/JP6313327B2/ja active Active
- 2013-12-12 EP EP13862590.0A patent/EP2931373B1/en active Active
- 2013-12-12 SG SG10201807682PA patent/SG10201807682PA/en unknown
- 2013-12-12 KR KR1020157017530A patent/KR101748712B1/ko active IP Right Grant
- 2013-12-12 ES ES13862590T patent/ES2759281T3/es active Active
-
2015
- 2015-06-09 IL IL239309A patent/IL239309A0/en unknown
- 2015-10-29 HK HK15110738.9A patent/HK1210077A1/zh unknown
-
2018
- 2018-03-22 JP JP2018055386A patent/JP6665218B2/ja active Active
- 2018-07-16 US US16/036,402 patent/US10688134B2/en active Active
- 2018-09-10 AU AU2018226514A patent/AU2018226514B2/en active Active
-
2020
- 2020-02-19 JP JP2020026138A patent/JP2020097618A/ja active Pending
- 2020-03-20 AU AU2020202022A patent/AU2020202022A1/en not_active Abandoned
- 2020-06-01 US US16/889,354 patent/US20200289578A1/en not_active Abandoned
-
2022
- 2022-02-18 JP JP2022024306A patent/JP7420844B2/ja active Active
- 2022-07-26 AU AU2022209219A patent/AU2022209219A1/en active Pending
-
2024
- 2024-01-11 JP JP2024002878A patent/JP2024041904A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201807682PA (en) | Methods of Treating or Preventing Respiratory Conditions | |
| BR112013011827A2 (pt) | ''respirador com peça facial filtrante que tem uma vedação facial moldada com sobreposição'' | |
| EP2560681A4 (en) | USE OF TAU FOR MONITORING IMMUNOTHERAPY | |
| HK1180320A1 (zh) | 嘧啶衍生物及其在治療呼吸系統疾病比如 中的用途 | |
| NZ778131A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
| IL248880B (en) | Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases | |
| HK1180322A1 (zh) | 嘧啶衍生物及其在治療呼吸系統疾病比如 中的用途 | |
| PH12013500892A1 (en) | Composition for use in the prevention and/or treatment of skin conditions and skin diseases | |
| WO2012093258A3 (en) | Irf5- related treatment and screening | |
| TN2012000511A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies | |
| MX2013013752A (es) | Pirfenidona y tratamiento anti-fibrotico en pacientes seleccionados. | |
| MX2013000674A (es) | Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer. | |
| TN2013000427A1 (en) | Modified acid alpha glucosidase with accelerated processing | |
| MX348708B (es) | Métodos para mejorar el desarrollo del cerebro y la función cognoscitiva al usar beta-hidroxi-beta-metilbutirato. | |
| WO2011119868A3 (en) | Hyper-spatial methods for modeling biological events | |
| NZ719185A (en) | Crystalline forms of therapeutic compounds and uses thereof | |
| MX2016009306A (es) | Reequilibrado inmunologico epicutaneo. | |
| WO2012047951A3 (en) | Human lung stem cells and uses thereof | |
| MX363507B (es) | Metodos para administrar óxido nítrico a la sangre arterial o arterializada. | |
| NZ602380A (en) | Peptides for vaccine against birch allergy | |
| SG195127A1 (en) | Methods of treating or preventing neurological diseases | |
| MX2011008179A (es) | Peptidos para vacuna. | |
| EP2582392A4 (en) | USE OF ANTAGONISTS OF A LYMPHOCYTE B STIMULATING PROTEIN FOR THE TREATMENT OF ASTHMA AND OTHER ALLERGIC AND INFLAMMATORY DISEASES OF THE RESPIRATORY SYSTEM | |
| MX2015012548A (es) | Metodos para estimular la maduracion de pulmones e intestinos infantiles. | |
| MX2015005111A (es) | Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada. |